Cencora has significantly amplified its efforts to combat drug shortages through the expansion of its sure supply program, a ...

Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...

U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation ...

Shares of Cencora Inc. COR slid 2.82% to $246.13 Thursday, on what proved to be an all-around mixed trading session for the ...

Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on ...

Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks ...

Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may ...